Biotage AB (publ) publishes its 2021 Annual Report

Biotage AB (publ) publishes its 2020 Annual Report, Corporate Governance Report and Remuneration Report

Biotage’s 2021 Annual Report, Corporate Governance Report and Remuneration Report are as of today available at: www.biotage.com

Contacts

---

Tomas Blomquist, President and CEO
Tel: [phone], [e-mail]

Maja Nilsson, CFO
Tel: [phone], [e-mail]

About Biotage

---

Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.

Biotage is contributing to sustainable science with the goal to make the world a healthier, greener and cleaner place – HumanKind Unlimited.

Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Website: www.biotage.com

This information is information that Biotage is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-04-07 10:30 CEST.

Attachments

---

CS3 3 Eng Annual Report 2021 English

© Modular Finance, source Nordic Press Releases